Geron Corp. diskutieren
Geron Corp.
WKN: 902213 / Symbol: GERN / Name: Geron / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,15 €
1,58 %
Geron Co. (NASDAQ: GERN) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for GERN provided by MarketBeat
Geron Co. (NASDAQ: GERN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Ratings data for GERN provided by MarketBeat
Geron Co. (NASDAQ: GERN) had its price target raised by analysts at Needham & Company LLC from $6.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for GERN provided by MarketBeat
Geron Co. (NASDAQ: GERN) had its price target lowered by analysts at B. Riley from $5.50 to $3.50. They now have a "buy" rating on the stock.
Ratings data for GERN provided by MarketBeat
Geron Co. (NASDAQ: GERN) had its price target lowered by analysts at Needham & Company LLC from $7.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for GERN provided by MarketBeat
Geron Co. (NASDAQ: GERN) had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for GERN provided by MarketBeat
Geron Co. (NASDAQ: GERN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for GERN provided by MarketBeat
Geron Corporation (NASDAQ: GERN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $1.00 price target on the stock.
Ratings data for GERN provided by MarketBeat
Geron (NASDAQ:GERN) had its price target lowered by analysts at Needham & Company LLC from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for GERN provided by MarketBeat
Neueste Beiträge
Roth_Capital in Discuss Vicor Corp.